Introduction
There can be little doubt that regular urine screening for the presence of misused drugs in urine has a salutary sentinel effect and, in time, reduces the proportion of positive tests in the population under scrutiny.' There is surprisingly little evidence that the testing of employees for evidence of drug misuse by urine analyses has any significant effect on accident rates. 2 Despite this the enactment of the Transport and Works Act 1992 into law has resulted in most operators of passenger transport systems in the UK introducing some form of urine drug screening for their operational staff. Other industries, such as the nuclear industry, the oil industry and companies doing work for the US federal government also have policies in place for employee urine drug screening.3 I wish to argue that the way in which employee urine drug screening is carried out in the Key words
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United Kingdom is often unlawful, does not adequately protect the rights of the employee and can create very serious ethical difficulties for the health care professionals involved in the process.
Urine drug screening
The Faculty of Occupational Medicine of the Royal College of Physicians has recommended that workplace drug screening should be done under the direction of occupational health physicians. 4 Under such circumstances the process is clearly a medical one involving a definite doctor-patient relationship.
The first step in the process is the collection of the urine sample. Employees may be informed that failure to attend to provide a sample on a particular day will be regarded as the equivalent of the provision of a positive sample. In many cases the nonprovision of a sample could lead to dismissal and would certainly lead to the exclusion of a candidate for employment when drug screening is done as part of a pre-employment medical examination. The collection process is normally supervised by a nurse or a specially trained "collection officer". This will inevitably result in a loss of privacy for the individual providing the urine sample. Before providing the sample the subject will normally be asked to complete a form in which she lists all the medication she is currently or has recently been taking and in which she consents to the analysis of the sample and the disclosure of the results to either a clinician or to an authorised person in the organisation requesting the analyses. The identification of the person providing the urine sample has to be verified, the sample has to be voided with a degree of supervision that obviates sample adulteration or substitution by the employee, or anyone else, and then placed in tamper-evident containers for transmission to the testing laboratory. Usually the urine provided is divided into two aliquots, both of which are sent to the laboratory. Only one of the aliquots will be analysed in the first instance, with the second being stored in case of a later challenge.
At the laboratory, after verification that the tamper-evident seals on the containers are intact, the urine is first analysed by an immunochemical bring any objective benefits in terms of a reduction in accidents at work. Obviously the exclusion of the intoxicated or drug-impaired worker from the workplace is very highly desirable. The benefits of excluding the worker who engages in the occasional use of intoxicants outwith working hours and who has a satisfactory working and sickness record are less apparent. Thus a major reason for the introduction of such policies by UK-based companies, outwith the transport sector, must be as a pre-emptive public relations measure intended to mitigate the adverse publicity that would result from the low-probability event of an accident involving an allegedly drug or alcohol-impaired employee. Under such circumstances, where there is no overriding public interest, the rights of the employee who is subject to such testing are paramount.
Who owns the sample?
One of the rights of employees that is often compromised by employers is that of access to their urine sample when a positive result is obtained that they wish to challenge. The usual practice at the time of urine sampling is to divide the sample into two parts, sealing both into tamper-evident containers. The employer retains both urine samples and both are usually submitted to the laboratory, although only one sample is analysed, the other being kept intact in case of a challenge. This practice can be contrasted with the statutory procedure for the collection of blood or urine samples from a driver who is suspected of being unfit to drive. Here the results of any analyses cannot be used by the prosecution unless the specimen provided by the driver is divided into two and the second part has been "supplied to the accused". The role of the health professional in workplace drug screening When medical practitioners become involved in the process of workplace drug screening then the employee will have a right of access to the records of the analyses done on his urine sample for it would be difficult to argue that the analyses were not carried out in connection with the medical care of the employee in the context of occupational health. '5 In addition, if the report of the analysis is to be considered to be a medical report, and the involvement of a medical review officer implies that it should be, then the employee has a clear legal right of access to the report before it is passed to management and on gaining such access has a clear legal right to request either that the report not be supplied to management or to request that the medical practitioner involved amend the report if she considers it to be incorrect or misleading. If the medical practitioner is unwilling to amend the report then she must, if requested, attach a statement outlining the employee's views on the relevant part of the report. '6 Similarly, the principle of freedom of choice in medical care would imply that it is unethical to restrict access by the patient to his urine sample simply as a matter of policy. If the employee is a patient of the occupational health physician when he supplies a urine sample for drug testing then the normal obligations and duties of the doctor-patient relationship exist, including the right of the patient to seek a further opinion, in this case a re-analysis of his sample by an analyst of his choice. Whilst not specifically referring to occupational health physicians, the General Medical Council enjoins doctors to respect the right of a patient to a second opinion. 7
Thus, there appears to be little legal and no ethical justification for the policy adopted by some occupational health departments or personnel departments in restricting the access of employees to the urine samples they have provided when employees wish to have those samples re-analysed or when they wish to see the records of the analysis.
Interpretation difficulties
Once the urine analysis has been carried out on behalf of the employer the results are scrutinised by a medical review officer before they are released to the employer. The medical review officer's role is to determine whether or not a positive analytical finding indicates drug misuse and, if so, to produce a report which will be forwarded to management. The production of a positive report indicating drug abuse may well result in disciplinary action against the employee, with termination of employment being a common outcome. Determining whether or not a positive analytical result indicates drug misuse is not as straightforward as might appear. For example, morphine can be detected in urine not only after heroin use but also a day or two after taking over-thecounter medicines containing codeine or even after eating biscuits containing poppy seeds.'8 Six-acetylmorphine, usually regarded as a specific marker of heroin use, is only present in urine for a day or less after heroin use and consequently its absence from urine may not exclude past heroin use.'9 Clearly, the interpretation of a finding of morphine in urine requires a considerable degree of expertise. Similar difficulties exist in the interpretation of the presence of other commonly misused drugs and their metabolites The interpretation of a finding of cannabinoids in urine may be particularly difficult, even if passive smoking is not an issue.20 Cannabinoids may be found in urine for many days after the last use of cannabis. Consider the situation of a non-cannabis user who attends a party one Saturday night at which, unknown to her, comestibles containing cannabis are being served. Cannabis is being smoked at the party, but she does not accept any. She consumes a considerable amount of alcohol and what is apparently an ordinary sweetmeat. She attributes her pleasant intoxication to the alcohol she has consumed and thinks no more of it. The next Monday she goes into work as usual and is asked to provide a urine sample as part of a workplace drug screening programme as she has done on several previous occasions. Her supervisor has noticed no deterioration in her performance at work and the sample has been requested as a routine random check. She is horrified when she learns that her urine sample has been reported as containing cannabinoids. She is interviewed over the telephone by the medical review officer who then reports that the cannabinoids are present in her urine as a result of drug abuse. Consequently she loses her job.
There are many ethical issues inherent in the medical review officer's role. This is particularly the case where an occupational health physician with a fiduciary relationship with the employee also acts as the medical review officer. Obviously, the normal requirements of consent to examination and permission for the disclosure of the results of the examination have to be adhered to and the medical review officer cannot be exempt from the requirement to act in good faith in the best interests of the patient, even though she is paid by the employer or a third party in contract with the employer. The situation is analogous to that of the forensic medical examiner (police surgeon) whose obligation to carry out an examination and make a report to a police officer only with the consent of the detained person he has been asked to examine is well established. 
